RA
CAMT icon

Royce & Associates’s Camtek CAMT Stock Holding History

Royce & Associates’s Portfolio CAMT Stock Details CAMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.4M Buy
210,711
+8,223
+4% +$1.46M 0.28% 91
2026
Q1 		$30.7M Buy
202,488
+15,698
+8% +$2.38M 0.3% 84
2025
Q4 		$19.9M Buy
186,790
+9,656
+5% +$1.08M 0.2% 152
2025
Q3 		$18.6M Buy
177,134
+38,550
+28% +$3.45M 0.19% 173
2025
Q2 		$11.7M Sell
138,584
-116,597
-46% -$7.86M 0.12% 248
2025
Q1 		$15M Buy
255,181
+3,788
+2% +$305K 0.16% 182
2024
Q4 		$20.3M Sell
251,393
-398
-0.2% -$31.3K 0.19% 158
2024
Q3 		$20.1M Sell
251,791
-8,836
-3% -$861K 0.18% 157
2024
Q2 		$32.6M Sell
260,627
-30,280
-10% -$2.89M 0.31% 91
2024
Q1 		$24.4M Sell
290,907
-30,061
-9% -$2.36M 0.22% 126
2023
Q4 		$22.3M Sell
320,968
-20,000
-6% -$1.22M 0.21% 139
2023
Q3 		$21.2M Sell
340,968
-37,060
-10% -$1.83M 0.22% 132
2023
Q2 		$13.5M Sell
378,028
-4,885
-1% -$140K 0.13% 216
2023
Q1 		$10.9M Buy
382,913
+17,900
+5% +$477K 0.11% 283
2022
Q4 		$8.02M Buy
365,013
+70,837
+24% +$1.64M 0.08% 353
2022
Q3 		$6.82M Hold
294,176
– – 0.08% 365
2022
Q2 		$7.31M Sell
294,176
-3,700
-1% -$106K 0.08% 375
2022
Q1 		$9.07M Sell
297,876
-707,884
-70% -$24.9M 0.08% 397
2021
Q4 		$46.3M Sell
1,005,760
-40,483
-4% -$1.72M 0.35% 53
2021
Q3 		$42.4M Buy
1,046,243
+9,650
+0.9% +$372K 0.32% 65
2021
Q2 		$39.1M Buy
1,036,593
+395,143
+62% +$13.4M 0.27% 84
2021
Q1 		$19.2M Buy
641,450
+235,250
+58% +$6.31M 0.13% 263
2020
Q4 		$8.9M Sell
406,200
-23,400
-5% -$448K 0.07% 407
2020
Q3 		$6.61M Sell
429,600
-30,000
-7% -$446K 0.07% 408
2020
Q2 		$5.78M Buy
459,600
+4,800
+1% +$54.6K 0.06% 422
2020
Q1 		$3.83M Buy
454,800
+42,300
+10% +$451K 0.05% 451
2019
Q4 		$4.47M Buy
412,500
+46,900
+13% +$488K 0.04% 515
2019
Q3 		$3.43M Buy
365,600
+126,100
+53% +$1.15M 0.03% 579
2019
Q2 		$2.02M Buy
239,500
+173,700
+264% +$1.6M 0.02% 721
2019
Q1 		$587K Buy
+65,800
New +$533K 0.01% 908

Other funds holding CAMT

UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YDMI
Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Royce & Associates's CAMT Position: Q2 2026 in Review

Royce & Associates increased its Camtek (CAMT) stake by 4.1% in Q2 2026, buying an estimated $1.46M and bringing the position to 210,711 shares worth $34.4M. The position accounts for 0.28% of the portfolio, ranked #91.

Royce & Associates first reported a position in CAMT in Q1 2019 and has held it in 30 quarters since. The position peaked at $46.3M in Q4 2021. 235 funds tracked by Wall St. Rank hold CAMT as of Q2 2026.

  • Royce & Associates held 210,711 shares of Camtek worth $34.4M as of Q2 2026.
  • Royce & Associates bought 8,223 Camtek shares in Q2 2026, an estimated $1.46M.
  • Camtek made up 0.28% of Royce & Associates's portfolio in Q2 2026, its #91 holding.
  • Royce & Associates first reported a position in Camtek in Q1 2019 and has held it in 30 quarters since.
  • Royce & Associates's Camtek position peaked at $46.3M in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Camtek as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.